Immune tolerance induction in patients with severe hemophilia A with inhibitors

BACKGROUND: Inhibitory antibodies to factor VIII (FVIII) are an important complication when managing patients with hemophilia A. Immune tolerance induction (ITI) has been regarded as a useful method for eradicating inhibitors. We report the results of a retrospective study in Korean patients with he...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryu, Ji Eun, Park, Young Shil, Yoo, Ki Young, Lee, Kyoo Duck, Choi, Yong-Mook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705051/
https://www.ncbi.nlm.nih.gov/pubmed/26770953
http://dx.doi.org/10.5045/br.2015.50.4.248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705051/
https://www.ncbi.nlm.nih.gov/pubmed/26770953
http://dx.doi.org/10.5045/br.2015.50.4.248

Ejemplares similares